The 'natural BHA' positioning ingredient — willow bark contains salicin, a glycoside that converts in skin to salicylic acid (slowly, at much lower concentrations). Used by clean brands (Ursa Major, Versed) as a gentler exfoliant alternative to synthetic SA. Performance is meaningful but modest — closer to a chronic-use tone-evening agent than a spot treatment.
Benefits
gentler salicylic acid alternative
anti-inflammatory polyphenols beyond salicin
well-tolerated by sensitive skin
Example uses
gentle resurfacing toners
acne-prone barrier formulas
sensitive-skin pore care
Mechanism of action
Aqueous and hydro-alcoholic extracts of white willow (Salix alba) bark deliver a complex polyphenol matrix dominated by salicin — a beta-glucoside that hydrolyses in skin and gut to saligenin (salicyl alcohol), which is then oxidised to salicylic acid. The skin conversion is slow and incomplete, producing far lower effective SA concentrations than direct SA formulations. The extract also contains anti-inflammatory flavonoids and tannins that contribute beyond the salicin pathway. Marketed as the 'natural BHA' but mechanistically distinct: lower SA bioavailability, broader polyphenol activity, and gentler exfoliation profile.
Clinical evidence · Emerging
Solid in-vitro and ex-vivo data on salicin conversion and anti-inflammatory polyphenol activity; finished-cosmetic clinical evidence is smaller; head-to-head against direct salicylic acid generally shows lower efficacy at equivalent labelled concentration.
Effective concentration range
1–5% standardised extract (salicin content varies <1% to 25% by supplier)
Formulation notes
Salicin content of commercial extracts ranges from <1% to 25% — enormous variability. Conversion to salicylic acid in skin is incomplete. Pairs naturally with niacinamide, centella, and zinc.
Watchouts
Marketing often equates willow bark extract directly to salicylic acid — they are not interchangeable in potency. People with aspirin allergies should patch test.
The 'natural salicylic acid' framing systematically oversells the conversion efficiency — willow bark at 1% salicin content delivers a small fraction of the SA bioavailability of a direct 1% salicylic acid product. Aspirin sensitivity (acetylsalicylic acid) is a theoretical patch-test prompt though clinically reactions are rare. Salicin content varies wildly across suppliers and rarely appears on consumer labels, making efficacy essentially unguessable from the INCI alone.
Market positioning
Sold by clean brands (Ursa Major, Versed, Youth To The People) as the gentle plant-derived alternative to synthetic salicylic. Honest position: a legitimate mild anti-inflammatory and lightly resurfacing botanical, lateral rather than equivalent to direct SA. The marketing equivalence overstates what the molecule delivers.
Comedogenicity
0 / 5
Sensitisation risk
Low
INCI & aliases
Salix Alba Bark Extract
salix alba · salicin · willow bark
Clean beauty perception
Strongly positive — checks the 'naturally derived' box for the BHA category.